Theratechnologies Inc. TH.TO Stock
Theratechnologies Inc. Price Chart
Theratechnologies Inc. TH.TO Financial and Trading Overview
| Theratechnologies Inc. stock price | 1.89 CAD |
| Previous Close | 1.27 CAD |
| Open | 1.27 CAD |
| Bid | 1.26 CAD x 0 |
| Ask | 1.27 CAD x 0 |
| Day's Range | 1.25 - 1.31 CAD |
| 52 Week Range | 1 - 3.75 CAD |
| Volume | 11.38K CAD |
| Avg. Volume | 14.79K CAD |
| Market Cap | 121.01M CAD |
| Beta (5Y Monthly) | 1.525252 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.25 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3 CAD |
TH.TO Valuation Measures
| Enterprise Value | 159.77M CAD |
| Trailing P/E | N/A |
| Forward P/E | -8.333333 |
| PEG Ratio (5 yr expected) | -15.45 |
| Price/Sales (ttm) | 1.4864372 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.963 |
| Enterprise Value/EBITDA | -7.819 |
Trading Information
Theratechnologies Inc. Stock Price History
| Beta (5Y Monthly) | 1.525252 |
| 52-Week Change | -58.60% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.75 CAD |
| 52 Week Low | 1 CAD |
| 50-Day Moving Average | 1.24 CAD |
| 200-Day Moving Average | 1.77 CAD |
TH.TO Share Statistics
| Avg. Volume (3 month) | 14.79K CAD |
| Avg. Daily Volume (10-Days) | 19.37K CAD |
| Shares Outstanding | 96.81M |
| Float | 86.92M |
| Short Ratio | 2.8 |
| % Held by Insiders | 0.83% |
| % Held by Institutions | 28.73% |
| Shares Short | 38.46K |
| Short % of Float | 0.040% |
| Short % of Shares Outstanding | 0.040% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | November 30, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | November 30, 2023 |
Profitability
| Profit Margin | -59.75% |
| Operating Margin (ttm) | -38.37% |
| Gross Margin | 70.94% |
| EBITDA Margin | -25.10% |
Management Effectiveness
| Return on Assets (ttm) | -20.78% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 81.41M CAD |
| Revenue Per Share (ttm) | 0.85 CAD |
| Quarterly Revenue Growth (yoy) | 7.29% |
| Gross Profit (ttm) | 56.22M CAD |
| EBITDA | -20434000 CAD |
| Net Income Avi to Common (ttm) | -48648000 CAD |
| Diluted EPS (ttm) | -0.71 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 29.16M CAD |
| Total Cash Per Share (mrq) | 0.3 CAD |
| Total Debt (mrq) | 65.99M CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.835 |
| Book Value Per Share (mrq) | -0.334 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12341000 CAD |
| Levered Free Cash Flow (ttm) | 10.36M CAD |
Profile of Theratechnologies Inc.
| Country | Canada |
| State | QC |
| City | Montreal |
| Address | 2015 Peel Street |
| ZIP | H3A 1T8 |
| Phone | 514 336 7800 |
| Website | https://www.theratech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 144 |
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; and TH1902, which is in Phase 1 clinical trials for the treatment of various solid tumors, including HR+ breast cancer, triple negative breast cancer, ovarian cancer, endometrial cancer, melanoma, thyroid cancer, small cell lung cancer, and prostate cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Q&A For Theratechnologies Inc. Stock
What is a current TH.TO stock price?
Theratechnologies Inc. TH.TO stock price today per share is 1.89 CAD.
How to purchase Theratechnologies Inc. stock?
You can buy TH.TO shares on the Toronto exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Theratechnologies Inc.?
The stock symbol or ticker of Theratechnologies Inc. is TH.TO.
Which industry does the Theratechnologies Inc. company belong to?
The Theratechnologies Inc. industry is Biotechnology.
How many shares does Theratechnologies Inc. have in circulation?
The max supply of Theratechnologies Inc. shares is 45.98M.
What is Theratechnologies Inc. Price to Earnings Ratio (PE Ratio)?
Theratechnologies Inc. PE Ratio is now.
What was Theratechnologies Inc. earnings per share over the trailing 12 months (TTM)?
Theratechnologies Inc. EPS is -1.25 CAD over the trailing 12 months.
Which sector does the Theratechnologies Inc. company belong to?
The Theratechnologies Inc. sector is Healthcare.